These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Controlling the AP Controller: Controller Performance Assessment and Modification. Hajizadeh I; Hobbs N; Samadi S; Sevil M; Rashid M; Brandt R; Askari MR; Maloney Z; Cinar A J Diabetes Sci Technol; 2019 Nov; 13(6):1091-1104. PubMed ID: 31561714 [TBL] [Abstract][Full Text] [Related]
43. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia. Ward WK; Castle JR; El Youssef J J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254 [TBL] [Abstract][Full Text] [Related]
44. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion. Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023 [TBL] [Abstract][Full Text] [Related]
46. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes. Dadlani V; Pinsker JE; Dassau E; Kudva YC Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816 [TBL] [Abstract][Full Text] [Related]
47. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor. Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834 [TBL] [Abstract][Full Text] [Related]
48. [From insulin pump and continuous glucose monitoring to the artificial pancreas]. Apablaza P; Soto N; Codner E Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340 [TBL] [Abstract][Full Text] [Related]
49. In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System. Garcia-Tirado J; Colmegna P; Corbett JP; Ozaslan B; Breton MD J Diabetes Sci Technol; 2019 Nov; 13(6):1054-1064. PubMed ID: 31679400 [TBL] [Abstract][Full Text] [Related]
51. Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings. Henry Z; Villar Fimbel S; Bendelac N; Thivolet C Diabetes Metab; 2022 Nov; 48(6):101396. PubMed ID: 36252880 [No Abstract] [Full Text] [Related]
53. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E; Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304 [TBL] [Abstract][Full Text] [Related]
54. Advances in Care for Insulin-Requiring Patients Without Closed Loop. Lal RA; Buckingham B; Maahs DM Diabetes Technol Ther; 2018 Jun; 20(S2):S285-S291. PubMed ID: 29916743 [No Abstract] [Full Text] [Related]
55. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID. Lewis D J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554 [TBL] [Abstract][Full Text] [Related]
56. Insulin Therapy and Diabetic Pregnancy. Napoli A Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066 [TBL] [Abstract][Full Text] [Related]
57. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429 [TBL] [Abstract][Full Text] [Related]
58. Automated Insulin Delivery-The Light at the End of the Tunnel. Turksoy K; Frantz N; Quinn L; Dumin M; Kilkus J; Hibner B; Cinar A; Littlejohn E J Pediatr; 2017 Jul; 186():17-28.e9. PubMed ID: 28396030 [No Abstract] [Full Text] [Related]
59. Evaluation of a Predictive Low-Glucose Management System In-Clinic. Buckingham BA; Bailey TS; Christiansen M; Garg S; Weinzimer S; Bode B; Anderson SM; Brazg R; Ly TT; Kaufman FR Diabetes Technol Ther; 2017 May; 19(5):288-292. PubMed ID: 28221823 [TBL] [Abstract][Full Text] [Related]
60. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes. Lal RA; Ekhlaspour L; Hood K; Buckingham B Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]